Recurrent Small Lymphocytic Lymphoma
Showing NaN - NaN of 12
Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker
Suspended
- Recurrent Aggressive Non-Hodgkin Lymphoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +13 more
- Polatuzumab Vedotin
- +3 more
-
Scottsdale, Arizona
- +11 more
Aug 23, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 14, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of
Active, not recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +22 more
- Ibrutinib
- +3 more
-
Scottsdale, Arizona
- +1 more
Aug 10, 2021
Anaplastic Large Cell Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Mature T-Cell and
Completed
- Anaplastic Large Cell Lymphoma
- +12 more
- Laboratory Biomarker Analysis
- Tipifarnib
-
Iowa City, Iowa
- +1 more
Apr 3, 2020
Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Denmark, Italy, United
Completed
- Chronic Lymphocytic Leukemia
- +8 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Rochester, Minnesota
- +4 more
Jun 20, 2019
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1
Completed
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- +8 more
- Bortezomib
- +5 more
-
Scottsdale, Arizona
- +1 more
Apr 4, 2019
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (rituximab, yttrium Y 90
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- rituximab
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jul 9, 2018
Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in United
Completed
- Chronic Lymphocytic Leukemia
- +2 more
- Akt Inhibitor MK2206
- +3 more
-
Scottsdale, Arizona
- +43 more
Aug 17, 2017
B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +2 more
- sunitinib malate
- +2 more
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Apr 28, 2014
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (biological, other,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +6 more
- rituximab
- +4 more
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Aug 23, 2013